Forum Archive Index - March 2004

["david.gibson" <david.gibson@k.co.nz>]

One of the most interesting Otago Biotech's - A2 Milk - has announced plans to list on the NZAX with a rights issue following a recent placement of shares to an institution at $0.10.

 

http://www.a2corporation.com/

 

Ordinary milk contains significant quantities of the beta Casein A1 (a Casein component of milk).  This molecule has been implicated in promoting diabetes, heart conditions and even promoting Autism in children!

 

The company makes money by licensing its genetic test for the A2 "gene" and has the branding of "A2 milk".  A2 milk herds produce minimal beta Casein A1 - this is milk as it was 10,000 years ago - and still is in certain African tribes.  (Initial studies pinpointed the benefits of A2 milk by observing that high milk consumption amongst certain african tribes produced none of the clinical conditions reported in other high milk consumption societies).

 

The good news is that the beta Casein's are destroyed in the cheese making process - so your occasional slice of Rochefort is safe!

 

Full commercialisation is very close - unlike other biotech's.  No expensive FDA trials to navigate through.

 

A very interesting company for your consideration and comment.

 

/dbg